Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
      • Local Voices Webinar
      • Connecting Creators and Users of Knowledge
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Alerts
  • Find GHSP on LinkedIn
  • Visit GHSP on Facebook
  • RSS
ORIGINAL ARTICLE
Open Access

A Comprehensive Strategy to Mitigate Institutional Maternal Mortality: Lessons From a Quality Improvement Initiative in Brazilian Maternity Hospitals

Paulo Borem, Andrea Keiko Fujinami Gushken, Ana Paula Gushken, Rodolfo de Carvalho Pacagnella, Ademir Jose Petenate, Paula Tuma, Livia Sanches Pedrilio, Santiago Nariño, Pierre Barker, Claudia Garcia de Barros and Sebastian Vernal on behalf of the Abraço de Mãe Collaborative group
Global Health: Science and Practice December 2025, 13(2):e2400130; https://doi.org/10.9745/GHSP-D-24-00130
Paulo Borem
aInstitute for Healthcare Improvement, Cambridge, MA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pborem{at}ihi.org
Andrea Keiko Fujinami Gushken
aInstitute for Healthcare Improvement, Cambridge, MA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Paula Gushken
aInstitute for Healthcare Improvement, Cambridge, MA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodolfo de Carvalho Pacagnella
bDepartamento de Ginecologia e Obstetrícia, Universidade de Campinas, Campinas, SP, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ademir Jose Petenate
aInstitute for Healthcare Improvement, Cambridge, MA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Tuma
aInstitute for Healthcare Improvement, Cambridge, MA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Livia Sanches Pedrilio
cEscritório de Excelência, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santiago Nariño
cEscritório de Excelência, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Barker
aInstitute for Healthcare Improvement, Cambridge, MA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Garcia de Barros
cEscritório de Excelência, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Vernal
cEscritório de Excelência, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PreviousNext
  • Article
  • Figures & Tables
  • Supplements
  • Info & Metrics
  • Comments
  • PDF
Loading

Figures & Tables

Figures

  • Tables
  • Additional Files
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    The “4 Rs” Flowchart for Sepsis and Hypertensive Disorders of Pregnancy (A) and for Hemorrhage (B)

    Abbreviations: C-section: cesarean delivery; MEOWS: Modified Early Obstetric Warning Score; QBL, quantity blood loss.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Correlation Between Implementation of MEOWS and the iMMR From Life-Threatening Conditions, June 2019 to March 2021

    Abbreviations: iMMR, institutional maternal mortality ratio; LTC, life-threatening condition; MEOWS, Modified Early Obstetric Warning Score.

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Run Chart of the Aggregated iMMR From All Causes of Death in the 19 Participating Hospitals, January 2018 to September 2021a

    a December 2019 to March 2021 represents the implementation period of the quality improvement initiative.

    Abbreviations: iMMR, institutional maternal mortality ratio.

  • FIGURE 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4

    Run Chart of the Aggregated iMMR Due to Life-Threatening Conditionsa in the 19 Participating Hospitals, January 2018 to September 2021b

    a Life-threatening conditions comprised postpartum hemorrhage, sepsis, and hypertensive disorders of pregnancy.

    b December 2019 to March 2021 represents the implementation period of the quality improvement initiative while April to September 2021included the post-implementation period.

    Abbreviations: iMMR, institutional maternal mortality ratio.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Primary Drivers of Improved Women’s Survival Around Birth and Associated Changes the Participating Hospitals Tested

    Primary Driver (what to do)Changes (how to do)
    Create a reliable process to identify patients with suspected LTCs.Use MEOWS in addition to the standard screening tool for all patients (MEOWS + screening tool).

    Add 2 questions for women with MEOWS (MEOWS ≥ 4 or a single parameter score of 3):

    • Can the patient have an infection (suspicion of sepsis)?

    • Can the patient have HDP?

    Create alert systems for the entire team when suspected LTC is identified through MEOWS ≥ 4 or a score of 3 on any parameter + yes in 1 of the 3 questions or blood loss ≥500 mL vaginal birth or ≥1,000 mL for cesarean delivery.
    Provide safe, reliable, and equitable care for all patients at admission, antepartum, postpartum, and discharge.Ensure the timely rescue of all patients with suspected LTC by competent and trained teams to apply the care bundles.
    Reassess all patients according to bundle recommendations using MEOWS.
    Ensure to escalate the care of all patients with any LTC.
    Train teams to adapt the care considering social and racial inequalities.
    Develop engaged care teams with knowledge of how to deal with LTCs, considering social and racial inequalities.Train teams from all departments to provide clinical assistance to patients with LTCs.
    Promote training in the Model for Improvement.
    Build capacity (process/people) in the organization to collect and publish measures disaggregated by race reliably.
    Develop a culture of safety and continuous improvement.Create highly effective interdisciplinary teams (huddles, SBAR for communication, adverse events analysis).
    Engage leaders to promote transparency, fair culture, and quality of care as a high organizational priority.
    Ensure that service is co-designed with patients, families, and community.Engage patients/family/community to co-design care processes.
    Improve transparency in communication with patients/family/community.
    • Abbreviations: LTCs, life-threatening conditions; MEOWS, Modified Early Obstetric Warning Score; HDP, hypertensive disorders of pregnancy; SBAR: Situation, Background, Assessment, Recommendation.

    • View popup
    TABLE 2.

    Care Bundles for Postpartum Hemorrhage, Sepsis, and Hypertensive Diseases of Pregnancy

    Care BundleItems in the Care Bundle
    PPH first response care bundlea
    • TROM: Tranexamic Acid, Reposição volêmica (IV fluids), Oxytocic drugs, and Massage (uterine)b

    • Treat each of the 4 “Ts” accordingly (tone, trauma, tissue, and thrombin)

    PPH second response care bundlec
    • Calculate shock index

    • Move patient to operation room

    • Treat each of the 4 “Ts” accordingly

    • Consider blood transfusion

    HDPs care bundle
    • Collect laboratory tests for preeclampsia

    • Magnesium sulfate loading dose

    • Magnesium sulfate maintenance dose

    • Control of blood pressure and respiratory rate

    • Recalculate MEOWS

    • Treat high blood pressure

    Sepsis care bundle
    • Measure lactate level

    • Obtain blood cultures prior to administration of antibiotics

    • Administrate antibiotics

    • Rapidly administer 500 mL IV solution

    • Apply vasopressor after IV fluid to maintain mean arterial pressure ≥65 mmHg

    • ↵a For blood loss ≥500 mL (vaginal birth) or ≥1,000 mL (cesarean delivery), regardless of altered vital signs.

    • ↵b After this BTS, a group or researchers published an article proposing E-MOTIVE36 instead of TROM. The elements of the bundle are the same, but arranged in a different order, which changes the acronym.

    • ↵c After applying the first response bundle and blood loss persists.

    • Abbreviations: BTS, Breakthrough Series; HDPs, hypertensive disorders of pregnancy; MEOWS, Modified Early Obstetric Warning Score; PPH, postpartum hemorrhage.

    • View popup
    TABLE 3.

    Characteristics of the Participating Institutions, by the Life-Threatening Condition Chosen for Improvement

    Life-Threatening Condition to ImproveNo. of InstitutionsType of AdministrationaMedian Live Births Between April 2018 and March 2021 (Range)
    Postpartum Hemorrhage7
    • 3 public (1 teaching)

    • 3 philanthropic

    • 1 social organization

    11,813 (3,814–19,377)
    Hypertensive Diseases of Pregnancy8
    • 4 public (1 teaching)

    • 2 philanthropic

    • 2 social organization

    7,055.5 (3,903–12,528)
    Sepsis4
    • 4 public (1 teaching)

    14,269 (5,828–27,597)
    • ↵a Public hospital: Health care facility that is owned, funded, and operated by the government or a government agency at the local, regional, or national level; Teaching hospital: a medical facility that is affiliated with a medical school or university and is actively involved in the training and education of medical students, interns, residents, and other health care professionals; Philanthropic hospital: health care institution that operates with a primary focus on providing medical services and care as part of its charitable mission; Social organization: health care institution managed by an organized group of individuals who come together to pursue common goals, share values, and establish structured relationships to achieve specific purposes.

    • View popup
    TABLE 4.

    Changes Documented in the Hospitals Before and After the BTS, by the “4Rs” Clinical Steps

    Clinical Step (The 4Rs)Before the BTSAfter 17 months of the BTS
    RecognizeMEOWS not included in existing tools and protocols for triage and vital signs monitoring in most participating hospitalsMEOWS was adopted across the hospitals.
    Inconsistency among HCWs in interpreting the urgency to act when faced with abnormal vital signs and managing clinical situationsThe HCW team is well-trained on tools and protocols using Job Instruction/TWI methods.
    Delayed critical interventions and compromised patient safety due to absence of a clear threshold for actionA clear threshold to act: if MEOWS score of 4 or greater, or a score of 3 in any single parameter, the HCW needs to ask if there is suspicion of sepsis or preeclampsia. With hemorrhage, the threshold is blood loss.
    RescuePredominant obstetrician-based decision-makingTeam-based care and standardized.
    Decision-making variable depending on HCW background experience and preferencesLeadership and frontline team trained in using data for decision-making and rapid cycle improvement.
    No QI capability to reflect on performance and improve systems of careHCWs use improvement sciences to systematically improve the quality of care.
    Significant variations in clinical care due to unclear protocols and clinical decision-makingCollaborative agreement on best practices and evidence-based interventions reduces care variation.
    ReassessNo standard tools or process to reassess the patients after interventionsMEOWS is the gold standard for reassessing patients after implementing care bundles or clinical interventions. There is a clear process for communicating patient status to the care team.
    ReferNo explicit standard tool during the transition of careMEOWS is undertaken for all patients requiring care transitions with a clear recommendation to act.
    No standard referral pathwaysStreamlined referral pathways to ensure optimal patient care.
    • Abbreviations: BTS, Breakthrough Series; HCW, health care worker; MEOWS, Modified Early Obstetric Warning Score; QI, quality improvement; TWI, Training Within Industry.

    • View popup
    TABLE 5.

    Number of Deaths per Period and the Estimated Number of Deaths Prevented, by Cause of Death

    Number of Deaths per PeriodEstimated Number of Deaths Preventeda
    Cause of Death

    Baseline:

    January 2018 to November 2019

    Implementation:

    December 2019 to March 2021

    Post-Implementation:

    April 2021 to September 2021

    During and After Implementation: December 2019 to September 2021
    Hypertensive Disorders of Pregnancy151150
    Postpartum hemorrhage153111
    Sepsis268018
    Others (all causes except the 3 analyzed life-threating conditions)4631105
    Total (3 life-threating conditions and other, except COVID-19)10253164
    Live Births133,471120,916
    • ↵a To estimate the number of deaths averted, we employed the following method: initially, we established a baseline by gathering data on maternal mortality within a defined timeframe preceding the intervention. Subsequently, we calculated the baseline maternal mortality rate by dividing the number of maternal deaths by the number of live births during that period. Using this rate, we projected the anticipated number of maternal deaths, multiplying the rate by the number of live births each month, commencing with the first month after the baseline period. This projection illustrated the expected number of maternal deaths had the intervention not been implemented. Throughout the project, we meticulously collected the actual number of maternal deaths each month. By subtracting the actual number of deaths from the projected number, we determined the difference, representing the number of deaths averted.

    • View popup
    TABLE 6.

    Variations in Care Bundle Practices Among Participating Hospitals, May 2019 to October 2021

    Care BundleItems in the Care BundleReporting Hospitals (N)Initial Control-Line (%)Final Control-Line (%)Variation (percentage points)
    MEOWSN/A197898+20
    PPH prevention actionsAssess hemorrhage risk16 of 19b92920
    Quantify blood loss5790+33
    10 IU oxytocin after delivery8099+19
    PPH first response care bundleTranexamic acid6 of 76390+27
    IV fluids7684+8
    Oxytocic drugs (higher dose)7687+11
    Uterine massage7489+15
    HDP care bundleMagnesium sulfate (loading dose)4 of 886860
    Magnesium sulfate (maintenance dose)5475+21
    Treat high blood pressurea87870
    Sepsis care bundleMeasure lactate level3 of 44288+46
    Obtain blood cultures prior to administration of antibiotics84840
    Administer antibiotic92920
    Rapidly administer 500 ml IV solution5393+40
    Apply vasopressor after IV fluid to maintain mean arterial pressure ≥ 65 mmHg91910
    • Abbreviations: HDP, hypertensive disorders of pregnancy; MEOWS, Modified Early Obstetric Warning Score; N/A, not applicable; PPH, postpartum hemorrhage.

    • a Hydralazine was the antihypertensive/vasodilator available in the participating hospitals.

    • ↵b The reporting hospitals varied from 5 to 16, reaching 16 in the last 3 months of the BTS.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    • Text s01, PDF - Text s01, PDF
PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 13 (2)
Global Health: Science and Practice
Vol. 13, No. 2
December 31, 2025
  • Table of Contents
  • About the Cover
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Comprehensive Strategy to Mitigate Institutional Maternal Mortality: Lessons From a Quality Improvement Initiative in Brazilian Maternity Hospitals
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Comprehensive Strategy to Mitigate Institutional Maternal Mortality: Lessons From a Quality Improvement Initiative in Brazilian Maternity Hospitals
Paulo Borem, Andrea Keiko Fujinami Gushken, Ana Paula Gushken, Rodolfo de Carvalho Pacagnella, Ademir Jose Petenate, Paula Tuma, Livia Sanches Pedrilio, Santiago Nariño, Pierre Barker, Claudia Garcia de Barros, Sebastian Vernal
Global Health: Science and Practice Dec 2025, 13 (2) e2400130; DOI: 10.9745/GHSP-D-24-00130

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Comprehensive Strategy to Mitigate Institutional Maternal Mortality: Lessons From a Quality Improvement Initiative in Brazilian Maternity Hospitals
Paulo Borem, Andrea Keiko Fujinami Gushken, Ana Paula Gushken, Rodolfo de Carvalho Pacagnella, Ademir Jose Petenate, Paula Tuma, Livia Sanches Pedrilio, Santiago Nariño, Pierre Barker, Claudia Garcia de Barros, Sebastian Vernal
Global Health: Science and Practice Dec 2025, 13 (2) e2400130; DOI: 10.9745/GHSP-D-24-00130
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • ABSTRACT
    • BACKGROUND
    • METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Funding
    • Author contributions
    • Competing interests
    • Footnotes
    • Notes
    • REFERENCES
  • Figures & Tables
  • Supplements
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Navigating Change, Sustaining Impact: GHSPs Mission in a Transformed Landscape
  • Google Scholar

More in this TOC Section

  • Patterns and Drivers of Packaged (Fortified) Maize Flour Purchase in Urban and Peri-Urban Kenya
  • Exploring a Road Map to Achieving Tobacco Endgame in sub-Saharan Africa: A Qualitative Study Among Stakeholders From 12 Countries
  • Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study
Show more ORIGINAL ARTICLE

Similar Articles

Johns Hopkins Center for Communication Programs

Follow Us On

  • LinkedIn
  • Facebook
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2026 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire